News from daiichi sankyo europe gmbh A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Sep 02, 2014, 11:50 ET One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines

Registry provides new insights into AF treatment decisions, including patients' quality of life and treatment satisfaction[1],[2] ESC...


Apr 02, 2014, 07:00 ET Daiichi Sankyo extends the PREFER in AF patient registry to provide additional insights into the long-term management of patients with atrial fibrillation

For European Media Only, Not for UK Media   Atrial fibrillation (AF) is the most common heart rhythm disorder[1] resulting in a...


Jun 25, 2013, 04:25 ET Congresso ESH 2013, dallo studio SEVITENSION nuove evidenze sull'efficacia della combinazione fissa olmesartan/amlodipina vs. perindopril/amlodipina nel controllo della pressione arteriosa centrale

Nel corso del 23° Congresso della Società Europea di Ipertensione sono stati presentati gli ultimi dati dello studio SEVITENSION, che...


Jun 25, 2013, 04:25 ET 23ème congrès européen sur l'Hypertension et la Protection Cardiovasculaire

De nouvelles données de l'étude SEVITENSION montrent la supériorité de l'association à doses fixes Sevikar®...


Jun 25, 2013, 04:25 ET 23º Congreso de la Sociedad Europea de Hipertensión - ESH 2013

El estudio SEVITENSION demuestra la superioridad de Sevikar® (olmesartán y amlodipino) frente a la combinación de perindopril...


Feb 06, 2013, 11:29 ET European patient registry in venous thromboembolism (VTE) - PREFER in VTE - enrols first patient

The registry plans to gather data from more than 4,000 patients with VTE across seven European countries, providing insights into the...